SyncThink, a Boston-based applying VR and eye-tracking to assess ability to focus as an indicator of concussion damage, has launched the next generation of its FDA-cleared EYE-SYNC platform.
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon ...
The US Food and Drug Administration (FDA) has granted breakthrough designation for SyncThink's Eye-Sync technology, a virtual reality eye-tracking platform that provides objective measurements to aid ...
Boston-based eye tracking company SyncThink has made major changes to its marketing materials since the FDA objected to its labeling in a warning letter. The letter is dated July 31st; MedCityNews ...
Philadelphia, July 30, 2025 – In a new study led by Children’s Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision ...
Most concussions resolve within 2–4 weeks, but 10–30% of patients may experience lingering symptoms. Diagnosis is clinical and may be supported by tools like eye tracking and advanced imaging. Early, ...
For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback